Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Single Nucleotide Polymorphisms Located in Tnfa, Il1rn, Il6r, and Il6 Genes Are Associated With Covid-19 Risk and Severity in an Iranian Population Publisher Pubmed



Rokni M1, 2 ; Sarhadi M3 ; Heidarinia M3 ; Mohamedkhosroshahi L1 ; Asghari S4 ; Sargazi S3 ; Mirinejad S3 ; Saravani R3, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Immunology, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  3. 3. Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran
  4. 4. Department of Immunology, Buali Hospital of Laboratory, Zahedan University of Medical Sciences, Zahedan, Iran
  5. 5. Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

Source: Cell Biology International Published:2022


Abstract

Cytokines play pivotal functions in coronavirus disease 2019 (COVID-19) pathogenesis. However, little is known about the rationale and importance of genetic variations associated with immune system responses, so-called “immunogenetic profiling.” We studied whether polymorphisms of IL6, IL6R, TNFA, and IL1RN affect the disorder severity and outcome in patients infected with COVID19. We recruited 317 hospitalized patients with laboratory-confirmed COVID-19 from Bu-Ali hospital and 317 high-risk participants who had high exposure to COVID-19 patients but with a negative real-time-polymerase chain reaction (PCR) test. Multiple regression analyses were applied. We indicated that participants carrying the A allele in TNFA-rs361525, G>A (p <.004), the C allele in IL1RN-rs419598 T>C (p <.004), the A allele in IL6R-rs2228145, A>C (p =.047) are more susceptible to develop COVID-19. In contrast, those who carry the G allele of IL6-rs2069827, G>T (p =.01), are more protected from COVID-19. Also, we compared the various genotypes regarding the disorder severity and poor prognosis; we found that the AA genotype in TNFA is related to more aggressive illness and bad prognostic in contrast to the other inflammatory cytokines' genotypes. In addition, a high level of inflammatory indications, such as neutrophil-to-lymphocyte ratio and systemic immune-inflammation index, was observed in deceased patients compared with the survived subjects (p <.0001). We advised considering inflammatory cytokines polymorphisms as the main item to realize the therapeutic response against the acute respiratory distress syndrome induced by the SARS-CoV-2 virus. © 2022 International Federation for Cell Biology.
Other Related Docs
18. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
26. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
29. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
34. Serological Tests for Covid-19: Potential Opportunities, Cell Biology International (2021)
41. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
43. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
45. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
46. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
49. Melatonin Could Be Beneficial in Sars-Cov-2 Therapy, Natural Products Journal (2021)
50. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)